Page 1,278«..1020..1,2771,2781,2791,280..1,2901,300..»

Study Finds Screening for Social Needs Lacking in Hospitals and Practices – The Cardiology Advisor

Posted: Published on November 7th, 2019

Social needs including food, housing, utilities, transportation and exposure to interpersonal violence are well known to be linked to health outcomes. Continue reading

Posted in Clinical Cardiology | Comments Off on Study Finds Screening for Social Needs Lacking in Hospitals and Practices – The Cardiology Advisor

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD – TCTMD

Posted: Published on November 7th, 2019

The presence of epicardial coronary spasm and increased microvascular resistance in patients with angina but without obstructive coronary artery disease is associated with an increased risk of major adverse cardiovascular events, according to the results of a small study. Patients with coronary spasm and a high index of microcirculatory resistance (IMR) had a significantly worse prognosis compared with those without vasospasm and a normal IMR (HR 6.23; 95% CI 1.21-118.48) over a median follow-up of 893 days Continue reading

Posted in Clinical Cardiology | Comments Off on Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD – TCTMD

Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,…

Posted: Published on November 7th, 2019

DUBLIN--(BUSINESS WIRE)--The "Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering. The global computed tomography (ct) scanners devices and equipment market was valued at about $6.9 billion in 2018 and is expected to grow to $8.04 billion at a CAGR of 3.9% through 2022. The Computed Tomography (CT) scanners devices and equipment market consists of sales of computed tomography (CT) scanners devices and equipment and related services Continue reading

Posted in Clinical Cardiology | Comments Off on Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,…

Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential – 24/7 Wall St.

Posted: Published on November 7th, 2019

For the first time in years, for 2019 active managers are outperforming index funds, and that should be a loud wake-up call to passive investors. After a more than 10-year bull market, the bull is tired. Continue reading

Posted in Clinical Cardiology | Comments Off on Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential – 24/7 Wall St.

Effects of genetic transfection on calcium cycling pathways mediated by double-stranded adeno-associated virus in postinfarction remodeling – DocWire…

Posted: Published on November 6th, 2019

OBJECTIVE: Restoring calcium sensor protein (S100A1) activity in failing heartsposes a promising therapeutic strategy. We hypothesize that cardiac overexpression of the S100A1 gene mediated by a double-stranded adeno-associated virus (scAAV) results in better functional and molecular improvements compared with the single-stranded virus (ssAAV). Heart failure was induced by coronary artery ligation. Continue reading

Posted in Cardiac Remodeling | Comments Off on Effects of genetic transfection on calcium cycling pathways mediated by double-stranded adeno-associated virus in postinfarction remodeling – DocWire…

Latest Research Report to uncover key Factors of Global Cardiovascular Repair And Reconstruction Devices Market – Market Research Base

Posted: Published on November 6th, 2019

Cardiovascular repair and reconstruction devices are segmented into heart valve repair, cardiovascular grafts and cardiovascular patches. There is an increase in demand for cardiovascular repair and reconstruction devices market due to the increase in prevalence of Congenital Heart Defects and technological advancements in molecular chemistry, clinical pharmacology, cell biology and vascular surgery. Access Report Details at: https://www.themarketreports.com/report/global-cardiovascular-repair-and-reconstruction-devices-market-research-report The global Cardiovascular Repair And Reconstruction Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025 Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Latest Research Report to uncover key Factors of Global Cardiovascular Repair And Reconstruction Devices Market – Market Research Base

The Montreal Heart Institute celebrates its 500th heart transplant – GlobeNewswire

Posted: Published on November 6th, 2019

First heart transplant in Canada was performed at the Montreal Heart Institute First heart transplant in Canada was performed at the Montreal Heart Institute Fondation de lInstitut de Cardiologie de Montral MONTREAL, Quebec, Oct. 31, 2019 (GLOBE NEWSWIRE) -- The Montreal Heart Institute is proud to announce that the milestone of 500 heart transplants has been successfully completed recently. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on The Montreal Heart Institute celebrates its 500th heart transplant – GlobeNewswire

Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT – Yahoo Finance

Posted: Published on November 6th, 2019

South San Francisco Nov 6, 2019 (Thomson StreetEvents) -- Edited Transcript of Cytokinetics Inc earnings conference call or presentation Thursday, October 31, 2019 at 8:30:00pm GMT * Ching W. Jaw * Robert I. Blum H.C. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT – Yahoo Finance

Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans – Pulmonary Fibrosis News

Posted: Published on November 6th, 2019

Investigational therapy AD-214 raised no safety concerns in preliminary studies in non-human primates, and AdAlta, the therapys developer, is now planning to launch a Phase 1 clinical trial in humans, the company announced. AD-214 is amodification of AdAltas original lead candidate for the treatment of pulmonary fibrosis (PF), AD-114. AD-214 contains two i-bodies modified antibodies that specifically target the protein CXCR4 Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans – Pulmonary Fibrosis News

The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 – Forbes

Posted: Published on November 6th, 2019

Healthcare is an industry that is currently being transformed using the latest technology, so it can meet the challenges it is facing in the 21st century. Technology can help healthcare organizations meet growing demand and efficiently operate to deliver better patient care. Here are 9 technology trends that will transform medicine and healthcare in 2020 Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 – Forbes

Page 1,278«..1020..1,2771,2781,2791,280..1,2901,300..»